University of Minnesota. Driven to Discover.
One patient is dead and one ill after contracting drug-resistant E coli after FMT.
Experts say two new reports provide deeper insight into how and why antibiotics are being used in US agriculture.
Cases have now reached 626 and could soon top the ignomious post-elimination record of 667, reached in 2014.
All 8 patients required hospitalization, and the earliest case dates back to 2016.
Thirteen people in 7 states have been sickened, and the manufacturer has issued a recall.
Though success has been shown in only 2 patients, recruitment of more patients is under way.
The FDA clears remdesivir for development under the Animal Rule.
The strategy is geared toward using newer data tools and focusing on higher-risk foods.
Approved for URI but not CRE, the drug might offer off-label prospects for the latter.
The new drug is a 'modernized' version of tetracycline, designed to address antibiotic resistance, but its clinical role isn't yet clear.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.